BioTime's Subsidiary Asterias Biotherapeutics, Inc. Settles Patent Interference Proceedings

Under the terms of the settlement agreement, the parties granted to each other a royalty free, fully paid license to each other's technology relating to endoderm lineage cells including definitive endoderm and gut endoderm cells, only to the extent necessary to allow the licensee to make, use, sell, offer for sale, or import endodermal lineage ... (more)

http://ift.tt/1kLhds7